{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:10:07Z","timestamp":1780668607274,"version":"3.54.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873594"],"award-info":[{"award-number":["81873594"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Chronic renal disease associated with X-linked Alport syndrome (XLAS) is relatively rare. However, due to the lack of specificity in the pathologic and clinical manifestations of the disease, it is easy to be misdiagnosed. In this study, we included three Chinese families with XLAS and used targeted NGS to find gene variants. In family X1, the 36-year-old male proband had hematuria, massive proteinuria, sensorineural deafness and ESRD at 33. <jats:italic>In silico<\/jats:italic> prediction showed the novel c.1424-4C &amp;gt; G variant reduced the score of the normal 3\u2019 splice site from 0.47 to 0.00 (according to BDGP). Transcriptional analysis from his peripheral blood cells indicated that it caused the insertion of an amino acid [p.(Lys474_Gly475insVal)]. In family X2, the proband was a 32-year-old male, who had hematuria, proteinuria, hypertension, hearing loss and progressed into ESRD at 30\u00a0years. He carried a novel missense variant c.2777G &amp;gt; T p.(Gly926Val). In family X3, the proband, a 16-year-old male, had hematuria, massive proteinuria, sensorineural deafness and ESRD; the results of renal pathological findings were consistent with AS. He carried a novel variant c.4529-2A &amp;gt; T, so did his mother with ESRD and probable XLAS. Bioinformatic analysis with BDGP showed that it abolished the acceptor site from 0.83 to 0.00. RT-PCR analysis from his kidney tissue indicated that it caused exon 50 skipping and exon 50 skipping along with inserting a cryptic exon derived from intron 49 p.[Gly1510Aspfs*11, Gly1510Alafs*35]. Another novel missense variant c.1552G &amp;gt; A p.(Gly518Arg) was identified in his mother and his aunt. No skewed X-chromosome inactivation was involved in these two female patients. In conclusion, four novel variants in <jats:italic>COL4A5<\/jats:italic> were identified and transcriptional analysis is essential to investigate the pathogenicity of intronic variants. Thus we found a rare event in a female patient with XLAS caused by two <jats:italic>COL4A5<\/jats:italic> variants <jats:italic>in trans<\/jats:italic>.<\/jats:p>","DOI":"10.3389\/fgene.2022.847777","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T06:13:54Z","timestamp":1647497634000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of Four Novel COL4A5 Variants and Detection of Splicing Abnormalities in Three Chinese X-Linked Alport Syndrome Families"],"prefix":"10.3389","volume":"13","author":[{"given":"Sai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leping","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.2349482","article-title":"Identification of Mutations in the COL4A5 Collagen Gene in Alport Syndrome","volume":"248","author":"Barker","year":"1990","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/asn.2009070784","article-title":"Genotype-phenotype Correlation in X-Linked Alport Syndrome","volume":"21","author":"Bekheirnia","year":"2010","journal-title":"Jasn"},{"key":"B3","doi-asserted-by":"publisher","first-page":"30716","DOI":"10.1074\/jbc.M004569200","article-title":"Type IV Collagen of the Glomerular Basement Membrane","volume":"275","author":"Boutaud","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12882-017-0735-y","article-title":"Phenotype Variability in a Large Spanish Family with Alport Syndrome Associated with Novel Mutations in COL4A3 Gene","volume":"18","author":"Cervera-Acedo","year":"2017","journal-title":"BMC Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.21037\/atm-21-3523","article-title":"Functional Assessment of a Novel COL4A5 Splicing Site Variant in a Chinese X-Linked Alport Syndrome Family","volume":"9","author":"Chen","year":"2021","journal-title":"Ann. Transl Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.matbio.2016.08.005","article-title":"Collagen IV Diseases: A Focus on the Glomerular Basement Membrane in Alport Syndrome","author":"Cosgrove","year":"2017","journal-title":"Matrix Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/ki.1985.63","article-title":"Genetic Heterogeneity of Alport Syndrome","volume":"27","author":"Feingold","year":"1985","journal-title":"Kidney Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/s0140-6736(88)90753-2","article-title":"Genetics of Classic Alport's Syndrome","volume":"332","author":"Flinter","year":"1988","journal-title":"The Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000502798","article-title":"A Novel COL4A5 Splicing Mutation Causes Skipping of Exon 14 in a Chinese Family with Alport Syndrome","volume":"6","author":"Gao","year":"2020","journal-title":"Kidney Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence Estimates of Predicted Pathogenic COL4A3-Col4a5 Variants in a Population Sequencing Database and Their Implications for Alport Syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"Jasn"},{"key":"B11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0002-9343(81)90571-4","article-title":"Alport's Syndrome","volume":"70","author":"Gubler","year":"1981","journal-title":"Am. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5858\/133.2.224","article-title":"Alport Syndrome and Thin Glomerular Basement Membrane Nephropathy: a Practical Approach to Diagnosis","volume":"133","author":"Haas","year":"2009","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s12020-019-01856-6","article-title":"Eleven Novel SLC12A1 Variants and an Exonic Mutation Cause Exon Skipping in Bartter Syndrome Type I","volume":"64","author":"Han","year":"2019","journal-title":"Endocrine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/ki.2013.479","article-title":"Milder Clinical Aspects of X-Linked Alport Syndrome in Men Positive for the Collagen IV \u03b15 Chain","volume":"85","author":"Hashimura","year":"2014","journal-title":"Kidney Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"12696","DOI":"10.1038\/s41598-019-48990-9","article-title":"Determination of the Pathogenicity of Known COL4A5 Intronic Variants by In Vitro Splicing Assay","volume":"9","author":"Horinouchi","year":"2019","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1681\/ASN.2018030228","article-title":"Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-Linked Alport Syndrome","volume":"29","author":"Horinouchi","year":"2018","journal-title":"Jasn"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport's Syndrome, Goodpasture's Syndrome, and Type IV Collagen","volume":"348","author":"Hudson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.asn.0000090034.71205.74","article-title":"X-linked Alport Syndrome: Natural History and Genotype-Phenotype Correlations in Girls and Women Belonging to 195 Families: a \"European Community Alport Syndrome Concerted Action\" Study","volume":"14","author":"Jais","year":"2003","journal-title":"Jasn"},{"key":"B19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1681\/asn.V114649","article-title":"X-linked Alport Syndrome","volume":"11","author":"Jais","year":"2000","journal-title":"Jasn"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1681\/asn.V991736","article-title":"Alport Syndrome and Thin Glomerular Basement Membrane Disease","volume":"9","author":"Kashtan","year":"1998","journal-title":"Jasn"},{"key":"B21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/ki.1996.113","article-title":"The COL4A5 Gene in Japanese Alport Syndrome Patients: Spectrum of Mutations of All Exons","volume":"49","author":"Kawai","year":"1996","journal-title":"Kidney Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrneph.2012.259","article-title":"Alport Syndrome-Insights from Basic and Clinical Research","volume":"9","author":"Kruegel","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/(sici)1098-1004","article-title":"The Clinical Spectrum of Type IV Collagen Mutations","volume":"9","author":"Lemmink","year":"1997","journal-title":"Hum. Mutat."},{"key":"B24","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00467-016-3565-4","article-title":"Functional Assessment of a Novel COL4A5 Splice Region Variant and Immunostaining of Plucked Hair Follicles as an Alternative Method of Diagnosis in X-Linked Alport Syndrome","volume":"32","author":"Malone","year":"2017","journal-title":"Pediatr. Nephrol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","article-title":"Evidence of Digenic Inheritance in Alport Syndrome","volume":"52","author":"Mencarelli","year":"2015","journal-title":"J. Med. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1681\/asn.2008020198","article-title":"X Inactivation, Female Mosaicism, and Sex Differences in Renal Diseases","volume":"19","author":"Migeon","year":"2008","journal-title":"Jasn"},{"key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/ng0994-77","article-title":"Identification of Mutations in the \u03b13(IV) and \u03b14(IV) Collagen Genes in Autosomal Recessive Alport Syndrome","volume":"8","author":"Mochizuki","year":"1994","journal-title":"Nat. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1046\/j.1523-1755.1999.00601.x","article-title":"Making the Diagnosis of Alport's Syndrome","volume":"56","author":"Pirson","year":"1999","journal-title":"Kidney Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1242\/dev.01037","article-title":"Collagen IV Is Essential for Basement Membrane Stability but Dispensable for Initiation of its Assembly during Early Development","volume":"131","author":"Po\u0308schl","year":"2004","journal-title":"Development"},{"key":"B30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/ndt\/gfp551","article-title":"X-inactivation Modifies Disease Severity in Female Carriers of Murine X-Linked Alport Syndrome","volume":"25","author":"Rheault","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"B31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: a Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41431-021-00858-1","article-title":"Consensus Statement on Standards and Guidelines for the Molecular Diagnostics of Alport Syndrome: Refining the ACMG Criteria","volume":"29","author":"Savige","year":"2021","journal-title":"Eur. J. Hum. Genet."},{"key":"B33","first-page":"9086","article-title":"Determination of the Pathogenicity of a Novel COL4A5 Missense Variant by CRISPR-Cas9 in Kidney Podocytes","volume":"13","author":"Sun","year":"2021","journal-title":"Am. J. Transl Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/ki.2011.452","article-title":"Incidence of Renal Failure and Nephroprotection by RAAS Inhibition in Heterozygous Carriers of X-Chromosomal and Autosomal Recessive Alport Mutations","volume":"81","author":"Temme","year":"2012","journal-title":"Kidney Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1432-1033.1981.tb05690.x","article-title":"A Network Model for the Organization of Type IV Collagen Molecules in Basement Membranes","volume":"120","author":"Timpl","year":"1981","journal-title":"Eur. J. Biochem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"585064","DOI":"10.3389\/fgene.2020.585064","article-title":"Six Exonic Variants in the SLC5A2 Gene Cause Exon Skipping in a Minigene Assay","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1038\/s41467-020-16605-x","article-title":"Development of an Exon Skipping Therapy for X-Linked Alport Syndrome with Truncating Variants in COL4A5","volume":"11","author":"Yamamura","year":"2020","journal-title":"Nat. Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"13193","DOI":"10.1016\/s0021-9258(17)36818-7","article-title":"Complete Primary Structure of the Sixth Chain of Human Basement Membrane Collagen, Alpha 6(IV). Isolation of the cDNAs for Alpha 6(IV) and Comparison with Five Other Type IV Collagen Chains","volume":"269","author":"Zhou","year":"1994","journal-title":"J. Biol. Chem."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.847777\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T06:13:59Z","timestamp":1647497639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.847777\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":38,"alternative-id":["10.3389\/fgene.2022.847777"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.847777","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,17]]},"article-number":"847777"}}